Multimodal Genomic Predictor of Immunotherapy Success
GEN,
Immune checkpoint inhibitor drugs have added a dimension to physicians’ arsenal in their fight against cancer.
Multimodal genomic analyses predict response to immunotherapy in lung cancer patients
7th Space Family Portal,
.newsblock { width: 200px; height:200px; float:right; padding-left:15px; padding-right:15px; } Researchers at Johns Hopkins…
Multimodal genomic analyses predict response to immunotherapy in lung cancer patients
MedicalXpress,
Lung cancer. Credit: Jennifer Fairman and Valsamo Anagnostou, Johns Hopkins University Researchers at Johns Hopkins Kimmel…
Multimodal Genomic Analyses Predict Response to Immunotherapy in Lung Cancer Patients
Newswise,
more news from this sourcecontact patient services Image 1 of 1 Credit: Jennifer Fairman and Valsamo Anagnostou, Johns Hopkins…